India · English
Centre To Cap Trade Margins At 30 Per Cent Of MRP For 110 Anti-Cancer Drugs, Including 35 Patented Medicines
New Delhi, October 8, 2026: The Centre has decided to cap trade margins at 30 per cent of maximum retail price for all non-scheduled anti-cancer drugs, covering branded and generic, domestic and imported, patented, and non-patented medicines, government sources said on Thursday. The move addresses excessive trade mark-ups and aims to improve affordability while ensuring continued availability of…
Read the full report at Free Press Journal →
About this page
AKHBAARI groups the same story across publishers so you can see who is reporting it and how they differ. The summary above is machine-generated from the publisher's own feed text and is labelled as such. The full report stays with the publisher, who holds copyright in it. See our editorial policy.